TOThaísa Cardoso de Oliveira

Thaísa Cardoso de Oliveira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Thaísa Cardoso de Oliveira has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The drug loading impact on dissolution and diffusion: a case-study with amorphous solid dispersions of nevirapine

    by Kayque Almeida dos Santos, Lucas José de Alencar Danda, Thaísa Cardoso de Oliveira, José Lamartine Soares-Sobrinho, Monica Felts de La Roca Soares

    Amorphous solid dispersions (ASDs) are a viable alternative to enhance the kinetic solubility of poorly water-soluble drugs. However, there is lack of discussion about the impact of drug loading on dissolution rate and drug diffusion across the membrane generated by supersaturation. So, it was obtained amorphous solid dispersions with nevirapine and polyvinylpyrrolidone K-30 by solvent evaporation method using different drug loadings (10%, 15% and 20% w/w). Thermal analysis, Fourier transform infrared spectroscopy and x-ray diffraction characterized the ASDs, indicating that there was a good miscibility between components which stabilized the drug in its amorphous state. The intermolecular interactions impacted on the ASDs in vitro performance, where they were evaluated to dissolution tests under different conditions and permeability studies. All amorphous systems had an increment in aqueous solubility compared to nevirapine alone, although 10% amorphous solid dispersion (SD 10) kept drug supersaturation at very high concentrations longer, preventing the drug recrystallization, having the greater drug flux on membranes and more intermolecular interactions among the components. Therefore, large quantities of the polymer are required for the stability of the amorphous drug, due to the increase in the number of intermolecular interactions.


  • Synthesis of Eudragit® L100-coated chitosan-based nanoparticles for oral enoxaparin delivery

    by Yuri Basilio Gomes Patriota, Igor Eduardo Silva Arruda, Antônia Carla de Jesus Oliveira, Thaisa Cardoso de Oliveira, Eliadna de Lemos Vasconcelos Silva, Luíse Lopes Chaves, Fábio de Oliveira Silva Ribeiro, Durcilene Alves da Silva, Mônica Felts de La Roca Soares, José Lamartine Soares-Sobrinho


  • Open Access

    Atividade anti-inflamatória dos óleos essenciais de três espécies de Lamiaceae: uma revisão de literatura

    by Lucília Aquino Freitas, Thaísa Cardoso de Oliveira

    Essential oils (EOs) are highly volatile, strong-smelling complex compounds that are extracted from aromatic plants and have about a dozen to several hundred components. The majority of these include terpenes (oxygenated or not), such as monoterpenes and largely sesquiterpenes in addition to phenols and phenylpropanoids. This ample composition gives it several actions such as antioxidant, antiseptic, bactericidal, fungicidal, among others. The objective of this work was to describe the anti-inflammatory properties of EO of three species of Lamiaceae (Rosmarinus officinalis, Origanum vulgare and Thymus vulgaris) found in the literature in the last ten years; and to compare the main constituents with their anti-inflammatory mechanisms of action. For this, a literature review was carried out using the keywords "anti-inflammatory", "essential oil", and the scientific names of the species including their english correlates in the databases - PubMed, Science Direct and Scielo. We excluded the articles of revision and those published prior to 2007. We conclude the diversified constitution of the assets in the EO in the same species or between different entailing in differentiated anti-inflammatory mechanisms. It was noticed that the EOs from R. officinalis presented 1.8 cineole, and both EOs from O. vulgare and T. vulgaris, carvacrol, as main constituents contributing to various anti-inflammatory mechanisms. The main mechanisms verified in the investigation were evidenced in experimental models, in vivo, by the reduction of edema in the paw of rats related to the inhibition of the release of prostaglandins with the administration of the EO of R. officinalis, in vivo in animals and in vitro in humans, by inhibition of the release of pro-inflammatory cytokines with the use of OE of O. vulgare acting on intestinal and dermal inflammation and, in vitro and in vivo in animals, for the effects on colitis, edema and endothelial inflammation with the use of OE of T. vulgaris by inhibiting genes related to interleukin production, COX-2 expression and leukocyte migration. This may enhance the use of EO as viable and natural alternatives to the conventional treatment of inflammation by avoiding or ameliorating side effects. However, further investigations are still needed to clarify the mechanisms of anti-inflammatory action of its isolated constituents as well as their possible toxic effects.